Autosomal News and Research

RSS
FDA awards research grants to boost product development for patients with rare diseases

FDA awards research grants to boost product development for patients with rare diseases

Cells expressing faulty CFTR channel to TNF-α can 'fix' cystic fibrosis cells

Cells expressing faulty CFTR channel to TNF-α can 'fix' cystic fibrosis cells

Study of genetic risk factors of IBD in African-Americans published in Gastroenterology journal

Study of genetic risk factors of IBD in African-Americans published in Gastroenterology journal

Shire acquires Foresight Biotherapeutics for $300 million

Shire acquires Foresight Biotherapeutics for $300 million

3SBio purchases entire equity interest in Zhejiang Wansheng

3SBio purchases entire equity interest in Zhejiang Wansheng

Study discovers potential link between inherited genome-wide DNA sequences and CAD

Study discovers potential link between inherited genome-wide DNA sequences and CAD

More support for amyloidosis as earliest AD biomarker

More support for amyloidosis as earliest AD biomarker

Scientific collaboration pinpoints genetic cause of rare form of blindness in newborn babies

Scientific collaboration pinpoints genetic cause of rare form of blindness in newborn babies

Non-invasive prenatal testing for Down's syndrome acceptable to parents

Non-invasive prenatal testing for Down's syndrome acceptable to parents

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

UC Davis researchers settle long-standing controversy surrounding Canavan disease

UC Davis researchers settle long-standing controversy surrounding Canavan disease

Managing autosomal dominant polycystic kidney disease: an interview with Dr Richard Sandford, University of Cambridge

Managing autosomal dominant polycystic kidney disease: an interview with Dr Richard Sandford, University of Cambridge

EMA's CHMP backs JINARC (tolvaptan) for autosomal dominant polycystic kidney disease

EMA's CHMP backs JINARC (tolvaptan) for autosomal dominant polycystic kidney disease

23andMe granted FDA approval to market direct-to-consumer genetic test under novel device classification

23andMe granted FDA approval to market direct-to-consumer genetic test under novel device classification

Hutchinson-Gilford Progeria Syndrome can be compared to normal aging, say scientists

Hutchinson-Gilford Progeria Syndrome can be compared to normal aging, say scientists

UAB Research Probes Molecular Basis Of Rare Genetic Disorder

UAB Research Probes Molecular Basis Of Rare Genetic Disorder

Researchers uncover new gene tied to incurable eye disorder

Researchers uncover new gene tied to incurable eye disorder

Two UTHealth professors selected as AAAS Fellows for their efforts to prevent blindness

Two UTHealth professors selected as AAAS Fellows for their efforts to prevent blindness

Progression to combined pituitary hormone deficiency common in IGHD

Progression to combined pituitary hormone deficiency common in IGHD

Chemical chaperone: A new therapeutic option for epilepsy

Chemical chaperone: A new therapeutic option for epilepsy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.